Literature DB >> 23100800

Efficacy of neuraminidase (NA) inhibitors against H1N1 strains of different geographical regions: an in silico approach.

Asad U Khan1, Shazi Shakil, Sunil K Lal.   

Abstract

This report described the efficacy of NA inhibitors against newly evolved strains of H1N1 viruses. This in silico study was designed to understand the mode of interactions of NA inhibitors with NA. Hence, ligand, oseltamivir, zanamivir and peramivir were docked with modeled NA, ACD65204 (USA/2007), BAA06717 (Japan/1992), ACE77988 (S. Korea/2005) and ACD65204 (USA/2007). This study is based on interaction energies. Ramachandran Z-scores for these modeled structures were found to be -0.998, -1.121, -0.870 and -1.023, respectively, which confirms the accuracy of the modeled structures. These interactions revealed that some of these interacting residues have remained conserved throughout all the pandemics. These amino acid residues were found to be R118, R152, R225, E277, E278, R293 and Y402. Moreover, our study concludes that peramivir is the most efficient inhibitor against NA of H1N1.

Entities:  

Keywords:  H1N1; NA inhibitor; Neuraminidase; Swine flu

Year:  2010        PMID: 23100800      PMCID: PMC3450193          DOI: 10.1007/s12088-009-0065-2

Source DB:  PubMed          Journal:  Indian J Microbiol        ISSN: 0046-8991            Impact factor:   2.461


  3 in total

1.  Computational study on new natural polycyclic compounds of H1N1 influenza virus neuraminidase.

Authors:  Ye Wang; Di Wu; Dahai Yu; Zhiyong Wang; Li Tian; Yanyan Wang; Weiwei Han; Xuexun Fang
Journal:  J Mol Model       Date:  2012-01-27       Impact factor: 1.810

2.  Interaction of CTX-M-15 enzyme with cefotaxime: a molecular modelling and docking study.

Authors:  Shazi Shakil; Asad Ullah Khan
Journal:  Bioinformation       Date:  2010-04-30

3.  Molecular docking analysis of new generation cephalosporins interactions with recently known SHV-variants.

Authors:  Asad Ullah Khan; Mohd Hassan Baig; Gulshan Wadhwa
Journal:  Bioinformation       Date:  2011-01-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.